Open Label Study to Evaluate the Safety and Efficacy of AK101 Injection Subcutaneously in Subjects With Psoriasis

Clinical trial NCT05509361 · COMPLETED

Trial details

NCT number: NCT05509361
Sponsor: Akeso
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Plaque Psoriasis

Start date: 2022-04-08
Primary completion: 2023-11-24
Enrollment: 950

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.